Low Expression of PCK2 in Breast Tumors Contributes to Better Prognosis via Inducing Senescence of Cancer Cells

Verification in cultured breast cancer cells indicated that phosphoenolpyruvate carboxykinase 2 (PCK2) was significantly inhibited after therapy treatment.